10/22/2020 7:13:57 AM
BD Announces Executive Leadership Appointments; Promotes Dave Hickey To President, Life Sciences Segment
10/22/2020 6:59:28 AM
BD Appoints Patrick Kaltenbach As EVP And Chief Technology Officer
10/5/2020 6:56:09 AM
BD Gets 510(k) Clearance For BD FACSLyric Flow Cytometer With Integrated BD FACSDuet Sample Preparation System
9/30/2020 3:22:13 AM
BD Announces CE Mark Of Antigen Test To Detect SARS-CoV-2 In 15 Minutes
9/23/2020 7:01:29 AM
BD Submits PMA Supplement To FDA To Enable ThinPrep® Pap Test™ PreservCyt® Solution
9/21/2020 7:01:43 AM
BD Says Three Recalls Designated As Class I By FDA; One Designated As Class II
9/9/2020 7:10:08 AM
BD Says New Head-to-Head Study Demonstrates Equivalency And Accuracy Of COVID-19 Rapid Point-of-Care Tests
8/17/2020 4:03:23 PM
BD Appoints Kristen Stewart As SVP Of Strategy And Investor Relations
8/6/2020 6:02:40 AM
BD Q3 EPS Down 35.8% To $0.97, Adj. EPS Down 28.6% To $2.20
7/30/2020 5:27:05 PM
BD Announces $24 Mln U.S. Government Investment To Support Scale Up Manufacturing Of COVID-19 Diagnosic Tests
7/27/2020 4:15:51 PM
BD Declares Quarterly Dividend Of $0.79/share, Payable Sept. 30/ Record Sept. 9
7/27/2020 4:11:44 PM
Becton, Dickinson and Company (BDX) Declares Quarterly Dividend of $ 0.79, Record Date 9/9/2020
7/21/2020 7:05:07 AM
BD Gets Addl. Orders For 177 Mln Injection Devices For U.S., Canada COVID-19 Vaccine Preparations